Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 306 (95%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 54 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LAMICTAL | 150MG | TABLET | Resolved | 2017-08-23 | 2018-03-16 | 20136 |
| LAMICTAL | 100MG | TABLET | Resolved | 2018-03-16 | 2018-05-26 | 43073 |
| LAMICTAL | 25MG | TABLET | Resolved | 2017-09-14 | 2018-02-16 | 22120 |
| LAMICTAL | 5MG | TABLET | Resolved | 2017-06-09 | 2017-09-13 | 12467 |
| LAMICTAL | 5MG | TABLET | Resolved | 2018-01-19 | 2018-01-23 | 36734 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-02-22 | 69396 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2019-05-17 | 2019-08-16 | 84337 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-02-21 | 2020-03-26 | 106829 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2021-11-26 | 2022-03-02 | 149987 |
| JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Actual shortage | 2023-11-23 | 2024-04-17 | 211335 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-02-19 | 2019-03-02 | 76337 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-12-18 | 2020-02-06 | 101563 |
| INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178691 |
| IMITREX | 5MG | SPRAY | Resolved | 2017-05-19 | 2018-02-08 | 10741 |
| IMITREX | 5MG | SPRAY | Resolved | 2018-10-26 | 2018-10-31 | 65623 |
| IMITREX | 5MG | SPRAY | Resolved | 2021-06-30 | 2021-07-10 | 141713 |
| IMITREX | 5MG | SPRAY | Resolved | 2021-12-10 | 2022-01-26 | 150930 |
| IMITREX | 20MG | SPRAY | Resolved | 2017-04-06 | 2017-05-26 | 5841 |
| IMITREX | 20MG | SPRAY | Resolved | 2017-06-06 | 2018-02-23 | 12156 |
| IMITREX | 20MG | SPRAY | Resolved | 2018-03-09 | 2018-04-27 | 42337 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CYCLOCORT | 0.1% | CREAM | Discontinued | 2017-11-02 | 2018-01-31 | 27816 |
| COACTIFED | 30MG 2MG 10MG | SYRUP | Discontinued | 2018-06-13 | 2018-06-13 | 52332 |
| CLINDETS | 1% | PAD | Discontinued | 2017-09-19 | 2017-09-19 | 22562 |
| CLAVULIN 875 | 125MG 875MG | TABLET | Discontinued | 2024-01-18 | 2024-01-18 | 216509 |
| CLAVULIN 500 F TAB | 125MG 500MG | TABLET | Discontinued | 2024-02-02 | 2024-02-02 | 218240 |
| CEFTIN - TAB 500MG | 500MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121049 |
| CEFTIN - TAB 250MG | 250MG | TABLET | Discontinued | 2020-07-24 | 2020-07-24 | 121046 |
| AVANDIA | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-09-01 | 113311 |
| AVANDIA | 4MG | TABLET | Discontinued | 2020-04-27 | 2020-12-11 | 113314 |
| AVANDIA | 8MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113317 |
| AVANDAMET | 500MG 2MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8077 |
| AVANDAMET | 1000MG 2.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8081 |
| AVANDAMET | 1000MG 4.00MG | TABLET | Discontinued | 2017-04-25 | 2017-04-26 | 8084 |
| AVANDAMET | 500MG 4MG | TABLET | Discontinued | 2017-04-25 | 2017-05-04 | 8087 |
| AMERGE | 1MG | TABLET | Discontinued | 2021-10-28 | 2022-08-09 | 148427 |
| AMERGE | 2.5MG | TABLET | Discontinued | 2021-10-28 | 2022-12-02 | 148430 |